TLR4 and rheumatoid arthritis: Nevertheless, the result of the clinical trial of an anti-TLR4 inhibitory antibody, NI-0101 [270], has shown that blocking TLR4 alone cannot significantly improve RA symptoms, for a patient who has established RA and has inadequate response from methotrexate.